In the Media | February 22, 2017

Five-year study to examine treatments for people with multiple myeloma

Cancer Type:

Blood Cancers

Cancer Topic:

Precision Medicine

Project Name:

Multiple myeloma molecular monitoring (M4) cohort study

Locations:

New Brunswick
Canada Wide

Related News & Events

Research Highlight|May 09, 2023

Pan-Canadian multiple myeloma study recruits 95 patients, finds those resistant to immunotherapy show T-cell exhaustion signatures

The pan-Canadian, TFRI-funded Multiple Myeloma Molecular Monitoring (M4) Study makes progress as researchers recruit 95 patients and find that those r...

In the Media|February 23, 2017

Saint John to head national cancer study

Oncologist and UNB Saint John professor picked by Terry Fox Research Institute

In the Media|February 22, 2017

Five-year study to examine treatments for people with multiple myeloma

A New Brunswick led team has been awarded $5 million from the Terry Fox Research Institute to find better treatments for people with an incurable form...

TFRI News|February 15, 2017

TFRI launches Pan-Canadian initiative to bring new hope to multiple myeloma patients

New Brunswick-led national research team aims for tailored treatments for patients with incurable multiple myeloma through Terry Fox Research Institut...

All News & Events

Five-year study to examine treatments for people with multiple myeloma

Funding Opportunities

Our Research

Impact

About Cancer

Updates

About Us

Contact